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ignaling from receptor tyrosine kinases (RTKs)* requires
the sequential activation of the small GTPases Ras and
Rac. Son of sevenless (Sos-1), a bifunctional guanine
nucleotide exchange factor (GEF), activates Ras in vivo
and displays Rac-GEF activity in vitro, when engaged in a
tricomplex with Eps8 and E3b1–Abi-1, a RTK substrate and
an adaptor protein, respectively. A mechanistic understanding
of how Sos-1 coordinates Ras and Rac activity is, however,
still missing. Here, we demonstrate that (a) Sos-1, E3b1,
and Eps8 assemble into a tricomplex in vivo under physio-
logical conditions; (b) Grb2 and E3b1 bind through their SH3
domains to the same binding site on Sos-1, thus determining
S
 
the formation of either a Sos-1–Grb2 (S/G) or a Sos-1–
E3b1–Eps8 (
 
S/E/E8) 
 
complex, endowed with Ras- and
Rac-speciﬁc GEF activities, respectively; (c) the Sos-1–Grb2
complex is disrupted upon RTKs activation, whereas the
 
S/E/E8
 
 complex is not; and (d) in keeping with the previous
result, the activation of Ras by growth factors is short-
lived, whereas the activation of Rac is sustained. Thus, the
involvement of Sos-1 at two distinct and differentially
regulated steps of the signaling cascade allows for coordi-
nated activation of Ras and Rac and different duration of
their signaling within the cell.
 
Introduction
 
A major mechanism of signal transduction by receptor ty-
rosine kinases (RTKs)* involves the activation of small
GTPases, among which Ras and Rac are pivotal (Scita et
al., 2000). There is evidence for hierarchical organization of
small GTPases in signal transduction pathways (Van Aelst
and D’Souza-Schorey, 1997; Hall, 1998; Scita et al., 2000).
In addition, regulators of small GTPase activity, such as the
guanine nucleotide exchange factor (GEF) son of seven-
less (Sos-1), appear to control different events in the sig-
naling cascade (for review see Bar-Sagi and Hall, 2000;
Schlessinger, 2000; Scita et al., 2000). A scenario can thus
be envisioned in which coordinated and/or sequential acti-
vation of small GTPases is achieved through the action of
the same regulator at multiple steps. The molecular mecha-
nisms involved, however, remain yet to be understood. Sos-1
is a well-known Ras-GEF (for review see Bar-Sagi, 1994;
Schlessinger, 2000), whose specific catalytic activity is en-
coded by its Cdc25-like domain (Bar-Sagi, 1994). Elegant
biochemical and genetic studies have clarified how the pro-
line-rich COOH-terminal tail of Sos-1 interacts with the
SH3-containing adaptor molecule Grb2 (Bar-Sagi, 1994).
Grb2 in turn displays a SH2 domain responsible for the
recruitment of the Grb2
 
–
 
Sos-1 complex to active, auto-
phosphorylated RTKs (Lowenstein et al., 1992; Ceresa and
Pessin, 1998). The relocalization of the complex to the
plasma membrane is thought to be sufficient for Sos-1 to
catalyze the exchange of guanine nucleotides on Ras, which
is also present at the membrane, with ensuing activation of
this small GTPase.
Active Ras (Ras-GTP) triggers a number of signaling cas-
cades, among which is the one connecting Ras to Rac, a
member of the Rho subfamily of small GTPases. There is
evidence that Sos-1 is also active at this step. First, Sos-1
contains a Dbl homology domain in tandem with a Pleck-
strin homology domain, a module responsible for GEF
activity on Rho GTPases (Cerione and Zheng, 1996; Nim-
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nual et al., 1998). Second, and most importantly, Sos-1 has
been shown to form a tricomplex in vivo with two signaling
molecules, Eps8 (Fazioli et al., 1993) and E3b1 (also known
as Abi-1) (Shi et al., 1995; Biesova et al., 1997). E3b1 con-
tains a SH3 domain and binds Sos-1 (Scita et al., 1999; Fan
and Goff, 2000). In addition, E3b1 binds to the SH3 do-
main of Eps8 (Biesova et al., 1997). Thus E3b1 acts as a
scaffold protein, which holds together Sos-1 and Eps8. The
tricomplex Sos-1
 
–
 
E3b1
 
–
 
Eps8 (S/E/E8) is endowed with Rac
GEF activity in vitro (Scita et al., 1999). Thus, the sum of
the above observation raises the possibility that Sos-1 might
function at different step in the signaling cascade, acting as a
Ras-GEF and a Rac-GEF, respectively. A number of out-
standing questions need clarification, however, before such a
model could be accepted: does a trimeric S/E/E8 complex
exist under physiological conditions? How is the specificity
of Sos-1 directed toward Ras or Rac? Does the putative dual
function of Sos-1 provide a mechanistic framework for the
coordinated activation of Ras and Rac? The present studies
were undertaken to elucidate these questions.
 
Results
 
The S/E/E8 complex exists under 
physiological conditions
 
In previous studies, we showed that Sos-1, E3b1, and Eps8
could form a trimeric complex in vivo upon concomitant
overexpression of the three proteins. However, we failed to
detect the existence of an endogenous S/E/E8 complex
(Scita et al., 1999). We reasoned that this could be due to
the low efficiency of the immunoprecipitating antibodies
used. We thus sought to exploit the availability of eps8
 
 
 
/
 
 
 
 fi-
broblasts to circumvent this problem. To this end, we per-
formed immunoprecipitation experiments using eps8
 
 
 
/
 
 
 
 fi-
broblasts in which the expression of Eps8 was restored, to
physiological levels, with an expression vector encoding a
myc epitope-tagged Eps8 (
 
 
 
/
 
 
 
 [Eps8myc] cells). We se-
lected transfected clones in which the levels of expression of
Eps8myc were very similar to those present in wild-type fi-
broblasts (Fig. 1 A). Endogenous Sos-1 and E3b1 could be
detected in anti-myc immunoprecipitates from lysates of
Eps8myc-reconstituted, but not from eps8
 
 
 
/
 
 
 
 fibroblasts
(Fig. 1 B).
To determine whether E3b1 mediates the interaction be-
tween Eps8 and Sos-1, as it would be expected according to
the tricomplex model, we performed coimmunoprecipita-
tion experiments under conditions in which the association
between Eps8 and E3b1 was disrupted. The binding site of
E3b1 to the SH3 domain of Eps8 was previously mapped to
the amino acid sequence, PPPPPVDYTEDEE, where the D
and the Y residues are critical for efficient binding (Mon-
giovi et al., 1999). Thus, a peptide encompassing this region
should specifically disrupt the Eps8–E3b1 association. In-
deed, no E3b1could be recovered in anti-myc immunopre-
cipitates from lysates of Eps8myc-reconstituted cells, when
the immunoprecipitation was performed in the presence of
an excess of the competing peptide. The association was,
however, preserved when a control peptide, bearing a Y
 
→
 
A
substitution and unable to bind to Eps8 (Mongiovi et al.,
1999), was used (Fig. 1 C). Similarly, no Sos-1 could be re-
covered in anti-myc immunoprecipitates in the presence of
the competing, but not of the control, peptide (Fig. 1 C).
Thus, under physiological conditions, the coimmunoprecip-
itation of Eps8 and Sos-1 depends on the integrity of the
Eps8–E3b1 interaction, pointing to the existence of a physi-
ological S/E/E8 complex. It cannot be formally excluded
that Eps8, E3b1, and Sos-1 associate after cell lysis, thus al-
lowing coimmunoprecipitation. However, we have previ-
ously demonstrated (Scita et al., 2001) that the three endog-
enous proteins also colocalize in vivo in dynamic actin
Figure 1. The S/E/E8 complex exists under physiological conditions. 
(A) Eps8
 /  cells were transfected with a control vector ( /  lanes) 
or a vector coding a myc epitope–tagged Eps8 ( /  [Eps8myc] 
lanes), both carrying a hygromicin resistance gene. Hygromicin-
resistant single-cell clones were established after 10 d of selection 
with hygromicin (0.2 mg/ml). The levels of Eps8, PDGFR, and EGFR 
in individual clones of eps8
 / ,  /  [Eps8myc], or in wild-type 
(WT) cells were determined by immunoblotting analysis of equal 
amounts of total cellular lysates (50  g) using the indicated antibodies 
(WB), and clones with levels of expression of Eps8, PDGFR, and 
EGFR similar to wild-type fibroblasts were used. (B) Total cellular 
lysates (10 mg), obtained from the transfectants described in A, were 
immunoprecipitated (IP) with the antibody indicated at the bottom 
(ctr, irrelevant antibody), followed by immunoblot with indicated 
antibodies (WB). The indicated lanes (lysates) were loaded with 100 
 g of total cellular lysates. (C) Total cellular lysates (10 mg) 
obtained from  /  [Eps8myc] cells were immunoprecipitated (IP) 
with the antibody indicated at the top (ctr, irrelevant antibody) in 
the presence or absence ( ) of 40 ng/ml of the indicated peptides 
(peptides). The peptides used were PPPPPVDYTEDEE (PXXDY) and 
PPPPPVDATEDEE (PXXDA, used as a control). Immunoblotting was 
with the indicated antibodies (WB). The indicated lanes (lysates) 
were loaded with 100  g of total cellular lysates. 
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structures. Thus, the sum of our results strongly argues in fa-
vor of the existence of a physiological S/E/E8 complex.
Similarly, it cannot be formally excluded that other inter-
actors of the SH3 domain of Eps8, besides E3b1, mediate
the formation of the endogenous trimeric complex. This is,
however, unlikely since no coimmunoprecipitation between
Eps8 and Sos-1 could be detected when the two proteins
were overexpressed in cell lines with relative low levels of
E3b1 (Scita et al., 1999; unpublished data). Moreover, nei-
ther RN-tre, nor JIK, two other known interactors of the
SH3 domain of Eps8 (Biesova et al., 1997; Mongiovi et al.,
1999), were able to bind to Sos-1 (unpublished data).
 
The adaptor molecules, E3b1 and Grb2, compete for 
binding to Sos-1 both in vitro and in vivo
 
Sos-1 has been shown to be part of a signaling complex with
Grb2, which mediates the activation of Ras upon RTK stim-
ulation. Our finding that, under physiological conditions,
Sos-1 also participates in a complex with Eps8 and E3b1
raises the question of the physical and functional relation-
 
ships between these two Sos-1–containing complexes. To
gain insight into this issue, we initially mapped the region of
E3b1 responsible for the interaction with Sos-1 by using a
series of deletion mutants of E3b1 fused to glutathione
 
S
 
-transferase (GST). Native Sos-1 could be efficiently recov-
ered onto GST-E3b1 full length (Fig. 2 A, amino acids [aa]
2–480). Further mapping revealed that the SH3 domain of
E3b1 (aa 416–480) was necessary and sufficient for binding
(Fig. 2 A).
We have previously shown that E3b1 binds to the proline-
rich, COOH-terminal tail of Sos-1 (aa 1131–1333) (Scita et
al., 1999), which also binds to the SH3 of Grb2 (Li et al.,
1993; Cussac et al., 1994). Thus, Grb2 and E3b1 might
compete for binding to Sos-1. This hypothesis was validated
by a series of experiments performed both in vitro and in
vivo. We could demonstrate that
 
 (
 
a) the SH3 of Grb2, but
not of Eps8, efficiently competed with the SH3 of E3b1 for
binding to the proline-rich COOH-terminal tail of Sos-1 in
vitro (Fig. 2 B); (b) the Sos-1 peptide VPVPPPVPPRRR,
known to constitute a Grb2-SH3 binding site (Li et al.,
Figure 2. In vitro competition between 
E3b1 and Grb2 for binding to Sos-1. 
(A, Top) schematic of E3b1. The ruler 
shows amino acid positions. (Bottom) In 
vitro binding of various fragments of 
E3b1 (all engineered as GST fusions, 
amino acid boundaries are indicated on 
the top) to Sos-1 from lysates of Sos-1–
transfected Cos-7 cells. Detection was 
with anti–Sos-1 antibody. The lane 
“lysate” was loaded with 50  g of total 
cellular lysates. P Rich, proline rich 
region; SH3, SH3 domain. (B) A His-
tagged COOH-terminal fragment 
(His-Sos, aa 1131–1333) of Sos-1 
(10 pmoles) was bound to 60 pmoles 
of either immobilized GST (GST) or 
GST-E3b1–331–480 in the presence of 
increasing concentrations of the NH2-
terminal SH3 domain of Grb2 or of Eps8 
(SH3s, 0, 10, 100, 1,000 pmoles, as indicated on the top). Detection was with antihistidine antibody. I, input, 10 pmoles of His-Sos-1. (C) 
His-Sos (10 pmoles) was bound to 60 pmoles of GST fusions encompassing the SH3s of either E3b1 (  and  ) or of Grb2 (  and  ). Binding 
was in the presence of the indicated amounts of the competing peptide NH2-VPVPPPVPPRRR-COOH (derived from the sequence of Sos-1, 
  and  ), or of a scrambled control peptide (  and  ). Detection was by immunoblot with anti-His, followed by densitometric scanning. (D) 
Kinetic analysis and rate constants for the binding of the SH3 domains of Grb2 and E3b1 to the proline-rich COOH-terminal of Sos-1 
(aa 1131–1333). Increasing concentrations (10–400 nM) of His-Sos-1 were passed over the immobilized GST fusion proteins (GST-SH3-Grb2 
and GST-SH3-E3b1) for 2.5 min at a flow rate of 50  l/min. The kinetics of binding are shown in the graphs. Coupling of equal amounts of 
the GST fusion proteins was performed with a goat anti-GST antibody covalently linked to CM5 sensor chip according to the manufacturer’s 
instructions. kon and koff kinetic rates were obtained by simple Langmuir fitting model (biaevaluation software v2.1).
Figure 3. In vivo competition between E3b1 and 
Grb2 for binding to Sos-1. (A, Top) GST-E3b1-
331–480, or control GST, was bound to Sos-1 
present in Cos-7 cells transfected (Tfx) with either 
Sos-1 or S/G. Detection was with anti–Sos-1. 
(Bottom) The same cellular lysates (50  g) were 
detected with anti-Grb2. (B) Lysates, from 293T 
cells transfected (Tfx) with E3b1 or a control vector 
(ctr), were immunoprecipitated (IP) with anti-Grb2 
or an irrelevant antibody (ctr), followed by 
detection (WB) with anti–Sos-1 (top) or anti-Grb2 
(middle). The expression of E3b1 (bottom) was 
detected with an anti-E3b1 antibody. 
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1993; Cussac et al., 1994), competed equally well the bind-
ing of the COOH-terminal tail of Sos-1 to the SH3s of Grb2
or E3b1 (Fig. 2 C); (c) the binding constants of the interac-
tion between the proline rich COOH-terminal tail of Sos-1
and the SH3 domains of Grb2 and E3b1 were very similar
(Fig. 2 D); (d) overexpression of Grb2 abolished the ability of
GST-E3b1 to bind to native Sos-1 (Fig. 3 A); and (e) overex-
pression of E3b1 significantly decreased the coimmunopre-
cipitation between Grb2 and Sos-1 (Fig. 3 B). Thus, Sos-1
binds either E3b1 or Grb2, in a mutually exclusive fashion,
suggesting that two distinct pools of Sos-1 exist in the cells.
To test this possibility in vivo, we set out to perturb the
equilibrium between the Sos-1–E3b1 (S/E) and Sos-1–
Grb2 (S/G) complexes, by increasing the levels of E3b1
within the cell. If the two complexes are functionally dis-
tinct, then the overexpression of E3b1, by competing the
S/G interaction, should result in (a) reduced Sos-1 recruit-
ment in vivo to active EGFR, (b) consequent reduction in
Ras activation, as measured by reduced Ras-GTP levels, (c)
reduced activation of Ras-dependent pathways, as mea-
sured by activation of MAPK, and finally (d) reduced pro-
liferative response. All of these predictions were confirmed
experimentally (Fig. 4, A–C).
We note that our mapping data are at variance with those
recently reported by Fan and Goff (2000), who concluded
that, in vivo
 
,
 
 the interaction between Sos-1 and E3b1–Abi-1
is mediated by the NH
 
2
 
-terminal portion of the latter. Con-
sistently, Fan and Goff (2000) did not observe competition
in vivo between Grb2 and E3b1 for binding to Sos-1. Al-
though we cannot exclude that the NH
 
2
 
-terminal region of
E3b1–Abi-1 participates in binding, in vivo
 
,
 
 we were not
able to observe a high-affinity binding surface in that region
by in vitro binding experiments (Fig. 2 A; Scita et al., 1999).
Conversely, under our conditions of analysis, the efficient
competition of the SH3 domains of Grb2 and E3b1 for
binding to the same Sos-1 peptide, coupled to the readily
detectable biological competition, strongly suggests that the
SH3-mediated contact is the major determinant of the inter-
action between Sos-1 and E3b1.
 
E3b1 is a limiting factor in Rac activation
 
The competition between E3b1 and Grb2 for the same bind-
ing site on Sos-1 implies that an individual Sos-1 molecule
can only be part of one GEF complex at a time. However, dif-
ferent pools of Sos-1, either bound to Grb2 or to E3b1, could
exist in vivo. We tried to gain insight into this issue. We
Figure 4. The S/G and the S/E 
complexes are functionally distinct. (A) 
Cos-7 cells were transfected with the 
indicated cDNAs (Tfx), and treated 
with EGF (3 min,  ) or mock treated 
( ). Immunoprecipitates (IP) with anti-
EGFR or preimmune sera (ctr) were 
analyzed by immunoblotting (WB) with 
anti–EGFR or HA (for Sos-1 detection). 
Lysates (50  g) were analyzed by 
immunoblotting with anti-EGFR, anti-
HA (for Sos-1 detection), or anti-E3b1 
antibody. HA-Sos, HA-epitope tagged 
Sos-1(B) Cos-7 cells were cotransfected 
(Tfx) with E3b1 (or a control empty 
vector, ctr) and either a myc-tagged 
Ras (left) or HA-tagged MAPK (right), 
followed by treatment with EGF (5 min, 
 ) or mock-treatment ( ). (Top, left) 
Ras-GTP was recovered with the 
GST-RBD of Raf-1 followed by immuno-
detection with anti-myc antibodies. (Top, 
right) Anti-HA immunoprecipitation, 
followed by immunodetection with an 
anti–phosphorylated MAPK antibody. 
The levels of expression of myc-Ras 
and HA-MAPK (middle) and E3b1 
(bottom) are also shown. (C) Quiescent 
NIH-3T3 fibroblasts were microinjected 
with an empty vector together with 
rabbit IgG (left) or with an HA-tagged 
E3b1 expression vector (right) followed 
by treatment with 10% serum. After
15 h, BrdU was added and 3 h later the 
cells were fixed and stained to detect 
BrdU incorporation (top), E3b1 (anti-
HA), or control (anti-IgG). Nuclei were 
counterstained with Dapi (bottom). A 
quantitative analysis of BrdU incorpora-
tion into control (empty bar) and E3b1 (closed bar) injected cells is shown on the right. The data are the mean   SEM of three independent 
experiments. Results are expressed as a percentage of injected cells incorporating BrdU respect to uninjected ones. Serum treatment 
induces BrdU incorporation in  95% of not injected cells. 
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showed that BIAcore measurements revealed similar kinetic
parameters for the SH3-mediated S/G and S/E interactions
(Fig. 2 D). However, when we measured the relative abun-
dance of S/G and S/E complexes within the cell, we found a
10-fold excess of the former (Fig. 5 A), under conditions in
which quantitative immunoprecipitation of the adaptor mole-
cules, Grb2 and E3b1, was achieved (Fig. 5 A). Thus, the data
indicate that two pools of Sos-1, associated with different
adaptors, exist simultaneously in the cell. They further suggest
that the pool of E3b1, available for binding to Sos-1, is re-
duced relative to that of Grb2, and may be rate-limiting. In-
deed, overexpression of E3b1 resulted in increased PAK65 ac-
tivity, an indicator of Rac activation (Manser et al., 1994)
(Fig. 5 B), which was abrogated by a dominant negative Rac
mutant (Fig. 5 B). On the other hand, overexpression of Sos-1
 
did not lead to increased PAK65 activity. An additional corol-
lary of this hypothesis is that the overexpression of E3b1, by
facilitating the formation of a trimeric complex with Eps8 and
Sos-1, should directly lead to activation of Rac. To test this
prediction E3b1 or a mutant of E3b1 (E3b1-DY), bearing
alanine substitutions of the DY residues critical for the inter-
action with Eps8 (Mongiovi et al., 1999), were used to infect
wild-type and eps8
 
 
 
/
 
 
 
 fibroblasts. The levels of GTP-bound
Rac were then determined by in vitro binding assays using the
immobilized CRIB domain of PAK65 (Manser et al., 1994).
E3b1, but not the E3b1 mutant impaired in Eps8 binding,
caused a readily detectable increase in Rac-GTP levels in wild
type, but not in eps8
 
 
 
/
 
 
 
 fibroblasts (Fig. 5 C). Thus, the over-
expression of E3b1 is sufficient to activate Rac and this effect
is strictly dependent on Eps8
 
.
Figure 5. E3b1 is a limiting factor in 
Rac activation. (Top, left) Lysates of 
Cos-7 cells were immunoprecipitated 
(IP) with the antibody indicated on the 
top and immunoblotted with the anti-
body indicated on the right. Lysate, 50 
 g of total cellular lysate. (Top, right) 
The efficiency of Grb2 and E3b1 immuno-
precipitations was  95%, as determined 
by immunoblot analysis of the superna-
tants of the immunoprecipitations 
performed with either the specific anti-
body with (Grb2 and E3b1, respectively, 
as indicated) or with an irrelevant (ctr) 
antibody. (Middle) Cos-7 cells were 
transfected (Tfx) with HA-tagged PAK65 
(all lanes) together with the plasmids 
indicated on the top (ctr, empty vector) 
and serum starved for 24 h. Equal 
amounts of anti-HA immunoprecipitated 
PAK65 were subjected to an in vitro 
kinase assay using myelin basic protein 
(MBP) as a substrate. The levels of 
immunoprecipitated PAK65 and the 
expression of Sos-1, E3b1, and 
HARacN17 in the various transfectants 
are also shown. Similar results were 
obtained using Cos-7 cells. (Bottom) 
Wild-type ( / ) and eps8
 /  ( / ) 
mouse embryo fibroblasts were infected 
with retroviral vectors coding for E3b1 
(E3b1) or the mutant of E3b1-DY 
(E3b1-DY), or with an empty vector 
as a control (ctr).  95% of the cells 
expressed the infected cDNA, as 
determined by immunostaining with 
anti-E3b1 (not shown). Equal amounts of 
lysates were subjected to in vitro binding 
assays with the immobilized CRIB 
domain of PAK65. After washing, bound 
proteins were resolved by SDS-PAGE 
and immunoblotted with anti-Rac anti-
bodies (Rac-GTP). The levels of total Rac 
(Rac) and E3b1 proteins are also shown. 
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The indispensability of E3b1 in the cascade of events lead-
ing to Rac activation and Rac-dependent actin reorganization
was further analyzed at the biological level. We have previ-
ously shown that interference with E3b1 functions, by micro-
injection of anti-E3b1 antibodies, inhibited PDGF-induced
ruffles (Scita et al. 1999). We also showed that in eps8
 
 
 
/
 
 
 
cells, ruffling induced by PDGF and activated Ras, but not by
activated Rac, was inhibited. Ruffling, however, could be re-
stored upon reexpression of Eps8, but not of an Eps8 mutant
unable to bind to E3b1 (Scita et al., 1999), suggesting that the
Eps8–E3b1-based complex is implicated in the transmission
of signal between Ras and Rac. Thus, one might predict that a
mutant of E3b1 unable to associate to Eps8 should function
as a dominant negative on Ras-induced Rac-dependent ruf-
fling. To test this, we cotransfected the activated versions of
either Ras or Rac, together with E3b1 or the E3b1DY mu-
tant. RasV12-induced, but not RacQL-induced, ruffles were
efficiently inhibited by the coexpression of E3b1DY, but not
of E3b1 wild type (Fig. 6), supporting the contention that the
ability of E3b1 to form a complex with Eps8 is required to
transmit signals from Ras to Rac. In conclusion, our data
show that two pools of Sos-1 exist in the cell, coupled respec-
tively to Grb2 or E3b1. In addition, the availability of E3b1,
but not of Sos-1, is indispensable and rate limiting in the
pathway leading to Rac activation.
 
The dual GEF activity of Sos-1 depends on its presence 
in distinct complexes
 
The existence of Sos-1 in two physically and functionally
distinct pools suggests the hypothesis that its presence in a S/G
or a S/E/E8 complex could dictate its Ras- or Rac-specific
GEF activities, respectively. To explore this possibility, we
used an in vitro assay that can score GEF activities in Sos-1–
containing immunoprecipitates. Cells were transfected with
Figure 6. The E3b1DY mutant inhibits actin remodeling induced by activated Ras, but not by activated Rac. Mouse embryo fibroblasts 
were transfected, as indicated on the top, with expression vectors for either RasV12 or RacQL, together with ECFP-tagged versions of either 
E3b1 or the E3b1DY mutant. After serum starvation, cells were fixed and stained with rhodamine-conjugated phalloidine to detect F-actin 
(top, red). Expression of the transfected proteins was detected (bottom, green) with either anti-Ras or anti-Rac antibodies or by epifluorescence 
(ECFP). In the cotransfection experiments a molar ratio of 1:3 of the activated GTPases to the ECFP-E3b1 constructs was used, such as that all 
of the epifluorescent cells expressed also the corresponding GTPase (not shown). The percent of transfected cells (mean   SEM) undergoing 
ruffling was as follow: RasV12   65   3%; RasV12   E3b1 WT   62   4%; RasV12   E3b1DY   16   2%; RacQL   93   3%; RacQL   
E3b1 WT   90   4%; RacQL   E3b1DY   95   5%. Bar, 10  m. 
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Figure 7. The bifunctional guanine nucleotide exchange activity of 
Sos-1 is regulated by its assembly into distinct molecular complexes. 
(A) Cos-7 cells were transfected with expression vectors for Sos-1 
(SosTfx) or for Sos-1, E3b1, and Eps8 (TripleTfx) or with the 
corresponding empty vectors (mock). Total cellular lysates (100  g, 
left), or immunoprecipitates (IP, right) with the antibody indicated on 
the top (ctr, irrelevant antibody), were immunoblotted (WB) with the 
indicated antibody. 5 mg of total cellular lysates were used for the 
immunoprecipitations, except in the SosTfx 1/10 lanes, in which 0.5 
mg were used. (B) Ras-GEF (empty bars) and Rac-GEF (closed bars) 
activities in aliquots of the same immunoprecipitates (IP) shown in B. 
Data are expressed as described in Material and methods. (C) Immo-
bilized, purified GST-Rac (Rac) and GST-Cdc42 (Cdc42) were 
depleted of guanine nucleotide by extensive washing in 10 mM 
EDTA as described in Material and methods. Equal amounts of the 
nucleotide-free GST-GTPases or GST alone (GST) were incubated 
with total cellular lysates from eps8
 /  fibroblasts ( / ) or eps8
 /  
stably expressing Eps8myc ( / [Eps8myc]) in the presence or ab-
sence ( ) of the 40 ng/ml of the indicated peptides (peptides). The 
peptide used were PPPPPPVDATEDEE (PXXDA), used as control (see 
text and Fig. 1); PPPPPVDYTEDEE (PXXDY), which corresponds to 
the E3b1 binding site for the SH3 domain of Eps8 and prevents 
Eps8-E3b1 association (refer to Fig. 1 B); VPVPPPVPPRRR (PXXP), 
which corresponds to the Sos-1 binding site for the SH3 domain of 
E3b1 and readily competes the interaction between Sos-1 and E3b1 
(refer to Fig. 2 C). Bound proteins were resolved by SDS-PAGE. 
Detection was with anti–Sos-1 antibody (Sos-1). The indicted lanes 
(lysate) were loaded with 50  g of total cellular lysates.
Figure 8. The differential regulation of the S/G and S/E/E8 
complexes by RTKs correlates with the kinetics of activation of 
Ras and Rac. (A) Mouse embryo fibroblasts cells were treated with 
PDGF for 15 min ( ) or mock treated ( ). Lysates were immunopre-
cipitated (IP) with anti-Grb2 (left) or anti-E3b1 (right) antibody and 
detected with anti–Sos-1 antibody (top) or anti-Grb2 (bottom, left), 
or anti-E3b1 (bottom, right). The indicated lanes (lysate) (50  g) 
were detected with anti–Sos-1 antibody to show the mobility shift 
after PDGF stimulation. Similar results were obtained upon EGF 
stimulation in Cos-7 cells (not shown). (B) Fibroblasts were treated 
with PDGF for the indicated lengths of time. Lysates were immuno-
precipitated (IP) with anti-PDGFR (PDGFR) or an irrelevant antibody 
as a control (ctr) and detected with the indicated antibodies (WB). 
(C)  /  [Eps8myc] cells were treated with 20 ng/ml of PDGF ( ) or 
mock treated ( ), and total cellular lysates were prepared. Immmuno-
precipitations (IP) were performed with anti-myc antibody or with 
an irrelevant (ctr) antibody, followed by immunoblot with the anti-
body indicated on the right (WB). The indicated lanes (lysates) were 
loaded with 100  g of total cellular lysates. (D) Fibroblasts were 
treated with PDGF for the indicated lengths of time. The levels of 
Ras-GTP and Rac-GTP in total cellular lysates were determined by 
affinity precipitation using GST-RBD and GST-CRIB, as described 
in Materials and methods. Elevated levels of Rac-GTP could be 
observed  30 min of RTK stimulation (not shown). The expression 
levels of Ras (total Ras) and Rac (total Rac), in the same lysates, 
were determined by immunoblotting with anti-Ras and anti-Rac 
antibodies, respectively. The kinetic of the mobility shift of Sos-1, 
after PDGF stimulation, was determined by immunoblotting with 
anti–Sos-1 antibodies. 
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Figure 9.
 
Proposed model for the roles of Sos-1 in the signaling pathway leading to activation of Rac.
 
 Under unstimulated conditions 
(unstimulated), Sos-1-based complexes, PI3K, and the small GTPases, Ras and Rac, are present in the cell in an inactive state. Immediately 
after stimulation (Stimulated: early events) by growth factor (G.F.), the S/G complex is recruited to the activated RTK at the plasma membrane, 
leading to Ras activation. GTP-loaded Ras, in turn, mediates signal propagation with the ensuing activation of Rac, through the trimeric 
complex S/E/E8 (dashed black arrow). In this pathway, PI3K, which binds to GTP-Ras, plays a key role, although it cannot be formally 
excluded that other Ras effectors may participate in the activation of Rac. Activation of Rac can also be achieved through Ras-independent 
 
either Sos-1 alone (SosTfx) or a combination of S/E/E8
(Triple Tfx) (Fig. 7 A). When Sos-1 was immunoprecipi-
tated from SosTfx, it displayed Ras-GEF, but not Rac-GEF,
activity (Fig. 7 B). Of note, little E3b1 and no Eps8 could
be detected in Sos-1 immunoprecipitates (Fig. 7 A). Con-
versely, Grb2 was readily recovered from the same immuno-
precipitates (unpublished data). We then used the Triple
Tfx and coimmunoprecipitated Sos-1 with anti-Eps8 anti-
bodies (Fig. 7, A and B). Under these conditions, all of the
coimmunoprecipitated Sos-1 is present in the S/E/E8 tri-
complex (Scita et al., 1999). Despite lower levels of Sos-1 in
the coimmunoprecipitate (with respect to a Sos-1 immuno-
precipitate from SosTfx), Rac-GEF activity was now present
(Fig. 7 B). Conversely, no Ras-GEF activity could be de-
tected (Fig. 7 B). The lack of Ras-GEF activity was not due
to the low levels of Sos-1. To prove this point, we immuno-
precipitated from SosTfx an amount of Sos-1 comparable to
that present in anti-Eps8 immunoprecipitates from Triple
Tfx (Fig. 7, A and B, lanes SosTfx1/10). Under these condi-
tions, Ras-GEF activity was readily detectable (Fig. 7 B).
The detection of Rac-specific GEF activity in anti-Eps8 im-
munoprecipitates strictly required the presence of Sos-1,
since no GEF activity was detected in Eps8 immunoprecipi-
tates, in the absence of coexpressed Sos-1 (Scita et al., 1999;
unpublished data). Furthermore, no Rac-GEF activity could
be detected in Eps8 immunoprecipitates from lysates of cells
transfected with Sos-1, E3b1, and an Eps8 mutant that is
impaired in its ability to bind E3b1 and thereby cannot
form a trimeric complex (Scita et al., 1999).
At this stage, we cannot formally exclude that an un-
known GEF, coprecipitating with Sos-1, is responsible for
the observed activity. However, such a hypothetical protein
should not only be associated with Sos-1, but also be active
only in the presence of Eps8 and E3b1, which are both re-
quired for the formation of the trimeric complex endowed
with Rac-specific GEF activity (Scita et al., 1999), making
this possibility unlikely. It is reasonable, therefore, to pro-
pose that Sos-1 alone (or complexed with proteins, such as
Grb2) is endowed with Ras-GEF activity. However, upon
interaction with Eps8 and E3b1, its specificity is switched
toward Rac.
A common feature of proteins endowed with GEF cata-
lytic activity is their ability to bind to their specific nucle-
otide-depleted GTPase with relative high affinities. Thus,
one might postulate that Sos-1 associates with the nucle-
otide-free form of Rac exclusively when engaged in the S/E/
E8 complex. Purified and nucleotide depleted, GST-Rac
and GST-Cdc42 proteins were therefore used to test their
ability to interact with Sos-1. Native Sos-1, present in lysates
of 
 
 
 
/
 
 
 
 [Eps8myc] fibroblasts, could be specifically recov-
ered with nucleotide-depleted immobilized GST-Rac, but
not with GST-Cdc42 or GST alone (Fig. 7 C). Conversely,
no Sos-1 could be recovered with GST-Rac from lysates of
eps8
 
 
 
/
 
 
 
 cells. Thus, Eps8 is required for the association be-
tween Sos-1 and nucleotide-free Rac. Furthermore, under
conditions in which the Eps8–E3b1 or the E3b1–Sos-1 in-
teractions were disrupted by specifically competing peptides,
a reduction of 
 
 
 
80% in the amount of Sos-1 bound to nu-
cleotide-depleted Rac was observed (Fig. 7 C). This latter re-
sult strongly suggests that an intact S/E/E8 complex is re-
quired for binding to Rac, providing a molecular basis for
the catalytic specificity of the complex.
 
RTK activation differentially regulates the S/G and
S/E/E8 complexes
 
Since S/G and S/E complexes are present in the cells simul-
taneously, then both Sos-1-dependent Ras- and Rac-GEF
activities are present at the same time. The question remains
as to how these two complexes, and the ensuing Ras and Rac
activities, are coordinated to achieve propagation of signals.
We therefore looked for evidence of differential regulation
of the S/G and S/E complex upon RTK stimulation. Upon
PDGF stimulation, we observed decreased coimmunopre-
cipitation between Grb2 and Sos-1 and consequently be-
tween PDGFR and Sos-1 (Fig. 8, A and B), which corre-
lated with the appearance of a mobility-retarded form of
Sos-1. This likely represents a hyperphosphorylated form of
Sos-1, as previously demonstrated (Baltensperger et al.,
1993; Cherniack et al., 1994; Pronk et al., 1994). Con-
versely, under identical conditions, the coimmunoprecipita-
tion between E3b1 and Sos-1 was not affected (Fig. 8 A).
Similarly, the stability of the endogenous trimeric complex,
Sos-1/Eps8/E3b1 was not affected by treatment of cells with
growth factors (Fig. 8 C).
The above data indicate that, as a consequence of activa-
tion of RTKs, the S/G complex is disrupted, whereas the
S/E/E8 complex persists in the cell. This might lead to a
transient peak in Ras activity vis a vis a more prolonged acti-
vation of Rac. Therefore, we measured the kinetic of RTK-
induced activation of Ras and Rac. As shown in Fig. 8 D, ac-
tivation of Ras was rapid and short lived, whereas activation
of Rac was sustained over a longer period of time, compati-
ble with the differential regulation of the corresponding acti-
vating complexes, S/G and S/E/E8.
 
Discussion
 
Previously, we have demonstrated that the genetically engi-
neered removal of Eps8 from mouse fibroblasts led to the ab-
rogation of the activation of the small GTPase Rac by RTKs
and/or activated Ras (Scita et al., 1999). Biochemically, this
effect was mirrored by the absence of Rac-specific GEF activ-
ity in extracts of Eps8-null cells (Scita et al., 1999). Sos-1
might be the GEF involved, as witnessed by the observations
that it forms a tricomplex with Eps8 and the scaffolding pro- 
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pathways, among which the one involving the direct recruitment of PI3K to activated RTK (dashed orange arrow). All these pathways 
converge on the S/E/E8 Rac GEF complex. Activated Rac finally mediates actin remodelling. Concomitantly, activated Ras leads to stimulation of 
the ERK kinase via the RAF-MEK-ERK cascade (solid red arrow). ERK can phosphorylate Sos-1 (dashed green arrow) with ensuing reduced 
affinity for Grb2, but not for E3b1. This results (Stimulated: late events) in the disassembly of the RTK-Grb2-Sos-1 complex contributing to the 
termination of Ras activation. Conversely, the trimeric complex S/E/E8 is stable, thus allowing sustained Rac activation through Ras-independent 
pathways (dashed orange arrow), which are most likely PI3K dependent, but could also be PI3K dependent. 
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tein E3b1 in vivo and that this tricomplex is endowed with
Rac-GEF activity in vitro (Scita et al., 1999). A model was
therefore proposed in which Sos-1 acted as a dual GEF, in-
volved in both Ras and Rac activation. In this study, after
showing that a S/E/E8 complex can exist under physiologi-
cal conditions, we investigated the molecular mechanisms
through which Sos-1 coordinates the activation of these two
small GTPases after RTK stimulation.
These results show that when Sos-1 is engaged in a multi-
molecular complex containing at least Eps8, E3b1, and Sos-1
itself (the contribution of other proteins cannot be ex-
cluded), it displays exclusive Rac specificity. This is mirrored
biochemically by the finding that Sos-1 binds to nucleotide-
depleted Rac only when its association with Eps8 and E3b1
is preserved. On the contrary, Sos-1 acts as a Ras-specific
GEF when alone or in association with Grb2 (Fig. 7; Buday
and Downward, 1993b). Thus, in light of these results and
previous finding, we conclude that a S/G complex directs
Ras activation through binding to RTKs, whereas a S/E
complex directs Rac activation by entering into a tricomplex
with Eps8 (Fig. 9).
The finding that Sos-1 participates in both Ras and Rac
activation does not immediately explain the temporal se-
quence by which the activation of Ras precedes that of Rac.
This latter concept, however, is largely based on the fact that
ectopic expression of a constitutively active Ras mutant is
sufficient to cause membrane ruffles, indicative of Rac acti-
vation (Bar-Sagi and Feramisco, 1986; Rodriguez-Viciana et
al., 1997; Scita et al., 1999). Current thinking holds there-
fore that active Ras, through binding and activation of phos-
phatidylinositol 3-kinase, leads to the formation of phos-
phatidylinositol 3, 4, 5 triphosphate, which in turn regulates
Rac-specific GEFs, like Vav-1, and possibly Sos-1 (Kotani
et al., 1994; Rodriguez-Viciana et al., 1994, 1996, 1997;
Han et al., 1998; Nimnual et al., 1998; Das et al., 2000)
(Fig. 9).
Our data and published literature highlight a much more
complex scenario. First, it is difficult to conceive how Rac
activation could be exclusively Ras dependent. In some cell
lines, such as Swiss 3T3, RTK-induced Rac activation is ap-
parently Ras independent (Ridley et al., 1992). In addition,
even in those cell lines in which a dominant negative Ras
mutant can suppress ruffle formation, the inhibition is never
quantitative (a maximum of 65 
 
 
 
 5% SEM inhibition of
PDGF-induced ruffling was observed in mouse embryo fi-
broblasts microinjected with a Ras dominant negative mu-
tant) (Scita, G., personal communication). Second, our ki-
netic data revealed that Rac activation persists long after the
return to basal levels of Ras-GTP, a finding not immediately
reconcilable with a simple and unique Ras
 
→
 
Rac pathway. It
seems therefore that multiple mechanisms could lead to Rac
activation from stimulated RTK (Fig. 9).
Nevertheless, signals appear to converge on a S/E/E8 com-
plex, as suggested by the fact that genetic and biochemical
interference with this complex leads to abrogation of Rac ac-
tivation induced by either active RTKs or dominant active
Ras and phosphatidylinositol 3-kinase mutants (Scita et al.,
1999). Our demonstration of differential regulation of the
stability of the S/G and S/E complexes sheds new light on
the molecular understanding of this circuitry. A dynamic in-
teraction between Sos-1 and Grb2 after RTK stimula-
tion has been previously reported (Buday and Downward,
1993a; Egan et al., 1993; Rozakis-Adcock et al., 1993;
Cherniack et al., 1994; Waters et al., 1995; Hu and Bowtell,
1996). Moreover, it is well established that upon EGF treat-
ment, Sos-1 is rapidly phosphorylated, mainly as a conse-
quence of MAPK activation (Cherniack et al., 1994; Roza-
kis-Adcock et al., 1995; Corbalan-Garcia et al., 1996; Porfiri
and McCormick, 1996), leading to a decrease in its affinity
for Grb2 (Corbalan-Garcia et al., 1996). Thus, the interac-
tion between Sos-1 and Grb2 is dynamically regulated by
RTK and might contribute to the rapid, but transient, acti-
vation of Ras after RTK stimulation (Fig. 8, A, B, and D).
Conversely, the S/E/E8 complex is stable under the same
conditions, and may account, at least in part, for the pro-
longed activation of Rac signaling (Fig. 8, A–D) and ruffling
activity (Ridley et al., 1992; unpublished data) (Fig. 9 shows
a proposed mode of action of Sos-1)
The shift in catalytic specificity of Sos-1, upon interaction
with Eps8 and E3b1 does not exclude the possibility that ad-
ditional mechanisms might participate in its action on Rac
in vivo. This is supported by the observation that the Rac-
specific GEF activity, detected in total cellular lysates and in
the immunoprecipitated trimeric S/E/E8 complex, is not ap-
parently affected by RTK activation (unpublished data).
GTP-bound active Rac accumulates on the plasma mem-
brane at sites where ruffling takes place (Kraynov et al.,
2000). Similarly, upon growth factor stimulation, Eps8,
E3b1, and Sos-1 are localized at the plasma membrane and
colocalize with F-actin within membrane ruffles (Proven-
zano et al., 1998; Scita et al., 1999, 2001), whereas Grb2
cannot be detected in these structures (Scita et al. 2001).
This provides a potential docking system for the Rac-based
signaling machinery and argues that differential localization
of adaptor molecules may further participate in the regula-
tion of Sos-1 biological activities. Although more work will
be needed to define the exact interplay of all components of
the circuitry, our findings of differential regulation of the S/G
and S/E complexes suggest an efficient mechanism for a
wave-like propagation of signals in which upstream signaling
is rapidly switched off after stimulation, whereas down-
stream signaling is still permitted (Fig. 9).
 
Materials and methods
 
Expression vectors and antibodies
 
CMV-based eukaryotic expression vectors and GST fusion or His-tagged
bacterial expression vectors were generated by recombinant PCR. Where in-
dicated, epitope tagging (either myc or HA) was also obtained by recombi-
nant PCR. The mutant of E3b1 (E3b1-DY), in which the D and Y residues
were replaced by A, was generated by PCR-based site directed mutagenesis
and cloned in the retroviral pBabe vector. All constructs were sequence ver-
ified. Details are available upon request. HA–Sos-1 was from Dr. D. Bar-Sagi
(Yang et al., 1995). Antibodies were anti-Eps8 (Fazioli et al., 1993), anti-
E3b1 (Biesova et al., 1997), and anti-EGFR sera (Di Fiore et al., 1990); rabbit
polyclonals anti–Sos-1, anti-Grb2, and anti-ERK-1; anti-PAK65, anti-PDGFR
(Santa Cruz Biotechnology); monoclonals anti-phosphoMAPK (New England
BioLabs), anti–v-H-Ras (Oncogene Science), anti–Histidine (Sigma Aldrich),
anti-BrdU (Becton and Dickinson), anti-HA11, and anti-myc 9E10 (Babco);
and anti-Rac (Transduction Laboratories).
 
Biochemical and functional assays
 
Protein analysis.  
 
Immunoprecipitation and coimmunoprecipitation were
performed as described (Fazioli et al., 1993). Briefly, cells were lysed on 
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ice with buffer containing 1% Triton X-100, 50 mM Hepes (pH 7.5), 150
mM NaCl, 5 mM EGTA, 1.5 mM MgCl
 
2
 
, 10% glycerol, 0.1 mM sodium
orthovanadate, 2 mM phenylmethylphosphate fluoride, 2 mM sodium py-
rophosphate 10 
 
 
 
g/ml aprotinin, and 10 
 
 
 
g/ml leupeptin. Immunoprecipi-
tations were performed for 2 h at 4
 
 
 
C, and immunocomplexes were recov-
ered by adsorption to protein A–Sepharose. After several washes with
buffer containing 0.1% Triton X-100, 20 mM Hepes (pH 7.6), 10% glyc-
erol, and 150 mM NaCl (washing buffer), immunoprecipiates were re-
solved be SDS-PAGE and analyzed by immunoblotting.
In vitro binding assays were performed as described (Fazioli et al.,
1993). GST fusion proteins were purified by affinity chromatography on
agarose-bound glutathione. His-tagged COOH-terminal tail of Sos-1 was
purified by affinity chromatography on agarose-bound Ni. For the in vitro
binding experiments, 5–60 pmol of purified immobilized GST fusion pro-
teins, or wild-type GST, were incubated with total cellular proteins (1–2
mg), prepared as described above. After several washing with washing
buffer, proteins were resolved by SDS-PAGE and analyzed by immuno-
blotting.
The in vitro binding to recombinant purified nucleotide-free GST-Cdc42
and GST-Rac was performed as described (Fan et al., 1998). Briefly, Rac1
and Cdc42, prepared as GST fusion proteins (20 
 
 
 
g) and immobilized on
glutathione–agarose beads (
 
 
 
1 mg protein/ml resin), were rendered free of
nucleotide by incubation for 20 min at 23
 
 
 
C in nucleotide-depleting (20
mM Tris-HCl, pH 7.5, 20 mM NaCl, 5% glycerol, 1 mM dithiothreitol,
0.1% Triton X-100) supplemented with 10 mM EDTA. Clarified lysates
were prepared from eps8
 
 
 
/
 
 
 
 or 
 
 
 
/
 
 
 
 [Eps8myc] cells in 20 mM Tris-Cl, pH
7.5, 150 mM NaCl, 1% Triton X-100, 1.0 mM PMSF, 10 
 
 
 
g/ml aprotinin,
and 10 
 
 
 
g/ml leupeptin. After incubation with total cellular lysates for 3 h
at 4
 
 
 
C, beads were washed extensively with nucleotide-depleting buffer.
Bound Sos-1 was determined by immunoblotting with anti–Sos-1 anti-
body.
The levels of Ras-GTP and Rac GTP were measured by affinity precipi-
tation using GST-RBD (Ras-binding domain) of Raf (Taylor and Shalloway,
1996) or GST-CRIB (Cdc42 and Rac Interactive Region) of PAK65 (Manser
et al., 1994), respectively, as previously described (Scita et al., 1999). The
activity of PAK65 was also measured as described (Manser et al., 1995).
Whenever indicated, treatment was performed with EGF (100 ng/ml) or
PDGF (20 ng/ml), after serum starvation, for the indicated lengths of time.
In vitro GEF activity toward Ras or Rac was performed as described
(Scita et al., 1999). Data are the mean 
 
 
 
 SEM of at least three independent
experiments performed in triplicate. Results are expressed as the [
 
3
 
H]GDP
released after 20 min relative to time 0, after subtracting the background
counts released in control reactions (obtained in the presence of a mock
immunoprecipitate).
Fibroblasts, seeded on gelatine, were microinjected with 100 ng/ml of
an empty vector together with rabbit IgG or of an HA-tagged E3b1 expres-
sion vector followed by treatment with 10% serum. After 15 h, BrdU was
added, three hours later the cells were fixed in 4% paraformaldheyde for
10 min, permeabilized in 0.1% Triton X-100 and 2% BSA for 10 min,
blocked with 2% BSA for 30 min and stained to detect BrdU incorporation
with anti-BrdU antibody, E3b1, or control microinjected cells with anti-
E3b1 and anti-rabbit IgG, respectively.
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